Rate My Professor Mark Habgood

Mark Habgood is a Senior Lecturer in the School of Translational Medicine at Monash University. He received his PhD in 1990 from the University of Southampton in the United Kingdom. Habgood has served as a research scientist in multiple blood-brain barrier laboratories prior to moving to Melbourne in 2001. His research specializations encompass the development of blood-brain barriers, the degree to which fetuses and neonates are exposed to maternally administered medications, maternal-fetal medicine, blood-brain barrier physiology, and spinal injury rehabilitation. He is also Director of a small research company that has pioneered ride-on sailing simulators to facilitate physical and social engagement for individuals across all physical abilities and ages, with a focus on spinal injury rehabilitation.

In addition to his research, Habgood coordinates units at Monash University, including Translational Medicine (TRM6008) and Clinical and Translational Neuroscience (TRM5005). He has produced 33 research outputs from 1991 to 2025, including 28 articles, 2 letters, 2 review articles, and 1 comment or debate contribution. Key publications include: "Effects of valproate on the entry of inert hydrophilic markers and expression of tight junction associated genes in the neonatal brain and choroid plexus of a rat model of epilepsy (GAERS)" (2025, Fluids and Barriers of the CNS); "Gestational Valproate Exposure Induces Tissue-Specific Transcriptomic Changes in the Neonatal Brain and Choroid Plexus in a Rat Model of Epilepsy, GAERS" (2025, European Journal of Neuroscience); "Paracetamol, its metabolites, and their transfer between maternal circulation and fetal brain in mono- and combination therapies" (2025, Pharmacological Reports); "ABC Efflux Transporters and Solute Carriers in the Early Developing Brain of a Marsupial Monodelphis domestica (South American Gray Short-Tailed Opossum)" (2024, Journal of Comparative Neurology); and "Effects of co-administration of lamotrigine on valproate transfer across the placenta and its brain entry in developing Genetic Absence Epilepsy Rats from Strasbourg (GAERS)" (2024, European Journal of Neuroscience). His work supports UN Sustainable Development Goals 3 (Good Health and Well-being) and 13 (Climate Action). Professional identifiers include ORCID 0000-0003-4227-5769 and Scopus ID 6701312558.